Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • kentnf
    Member
    • Jan 2009
    • 26

    Different results produced by tophat?

    I use tophat to map my strand-specific RNA-seq seqs and its reverse complementary seqs to genome, but the results have a little difference.

    For example, I have 5700000 seqs in one sample after sequencing, 5000000 of them mapped to genome by tophat. For reverse complementary seqs, maybe 4998000 of them were mapped to genome.

    command I used:
    $tophat -o output1 --segment-mismatches 0 genome_index RNA-seq.fa

    Then I compare mapped seqs of different results. There are 50000 seqs in the results A (5000000 mapped, normal strand) are not present in result B (4998000 mapped, reverse complementary strand). Another 50000 seqs are not present in result A but included in result B.

    Who can tell me why the results is different ? Thanks.
  • Daehwan
    Member
    • Oct 2010
    • 27

    #2
    I think it's probably due to quality values, you know, the quality value of each base usually decreases from left to right. So, if we reverse-complement a read, the read will have low quality values in its first several bases and therefore it's less likely for the read to be mapped to a genome. Perhaps you check this running Bowtie with the original reads and the reverse-complemented reads as TopHat is based on Bowtie.

    Bowtie allows 0~3 mismatches in the SEED of a read, which is 28bp by default, and allows additional mismatches in the rest depending on the sum of quality values, which I understand.


    Regarding each 50,000 seq difference between the results A and B, TopHat divides unmapped reads into several segments to find novel junctions, and a set of segments from the original reads can be different from that of segments from the reverse-complemented reads depending on the read length and the segment length, rendering different set of putative junctions.

    Other than this, the new version of TopHat at <http://tophat.cbcb.umd.edu/index.html> supports strand-specific RNA-Seq if you want to try it.

    Thanks,
    Daehwan
    Last edited by Daehwan; 10-27-2010, 10:06 AM.

    Comment

    • kentnf
      Member
      • Jan 2009
      • 26

      #3
      Thank you Daehwan.

      Before map reads to genome using tophat, contamination has already been cleaned. So I use fasta as input of tophat. And then I use bowtie map forward and reverse seqs to genome, the results are same.

      After check the cigar field of sam file, I think you are right. All the different parts of forward and reverse results are unmapped reads. When I set the parameter -a to 4, the different parts of results are reduced.
      Originally posted by Daehwan View Post
      Regarding each 50,000 seq difference between the results A and B, TopHat divides unmapped reads into several segments to find novel junctions, and a set of segments from the original reads can be different from that of segments from the reverse-complemented reads depending on the read length and the segment length, rendering different set of putative junctions.
      And I will try the new version of tophat. Thanks again

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      28 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Working...